Literature DB >> 7041936

An oral buprenorphine and paracetamol combination compared with paracetamol alone: a single dose double-blind postoperative study.

R E Bullingham, H J McQuay, R A Moore, L Weir.   

Abstract

1 An oral combination of buprenorphine and paracetamol was compared with paracetamol alone in a single dose, double-blind postoperative study. One hundred and twenty patients undergoing elective minor orthopaedic operations were allocated to four groups of 30 patients. The four treatments were 1,1.5 or 2 mg of buprenorphine with paracetamol 1,000 mg or paracetamol 1,000 mg alone. 2 There were no significant differences between the groups in analgesia measured by the observer over the 6 h period of direct observations. The oral opiate produced a significant increase in duration of analgesia beyond the 6 h study period. A significant increase in side-effects was seen only at the highest buprenorphine dose compared with paracetamol. 3 The problems of trial design for analgesic combinations are considered. Drug mixtures create additional complexities which decrease the certainty of the conclusion that no real benefits result from such mixtures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7041936      PMCID: PMC1401930          DOI: 10.1111/j.1365-2125.1981.tb01322.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

2.  Clinical experience with diamorphine in advanced malignant disease.

Authors:  R G Twycross
Journal:  Int J Clin Pharmacol       Date:  1974-04

3.  Overdosage of buprenorphine: case report.

Authors:  C D Banks
Journal:  N Z Med J       Date:  1979-04-11

4.  Analgesic methodology: a brief history and commentary.

Authors:  L Lasagna
Journal:  J Clin Pharmacol       Date:  1980 May-Jun       Impact factor: 3.126

5.  Clinical effects of buprenorphine during and after operation.

Authors:  H J McQuay; R E Bullingham; G M Paterson; R A Moore
Journal:  Br J Anaesth       Date:  1980-10       Impact factor: 9.166

6.  Buprenorphine kinetics.

Authors:  R E Bullingham; H J McQuay; A Moore; M R Bennett
Journal:  Clin Pharmacol Ther       Date:  1980-11       Impact factor: 6.875

7.  Effect of restrictions on prescribing patterns for dextropropoxyphene.

Authors:  G M Shenfield; A N Jones; J W Paterson
Journal:  Br Med J       Date:  1980-09-06

8.  Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis.

Authors:  R E Bullingham; H J McQuay; D Dwyer; M C Allen; R A Moore
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  8 in total
  5 in total

Review 1.  Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic review.

Authors:  E Montané; A Vallano; C Aguilera; X Vidal; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2006-09-21       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

3.  Some patients don't need analgesics after surgery.

Authors:  H J McQuay; R E Bullingham; R A Moore; P J Evans; J W Lloyd
Journal:  J R Soc Med       Date:  1982-09       Impact factor: 5.344

4.  Codeine added to paracetamol induced adverse effects but did not increase analgesia.

Authors:  P Skjelbred; P Løkken
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

5.  Post-operative Analgesia in Opioid Dependent Patients: Comparison of Intravenous Morphine and Sublingual Buprenorphine.

Authors:  Shaabanali Alizadeh; Ghafar Ali Mahmoudi; Hassan Solhi; Bahman Sadeghi-Sedeh; Reza Behzadi; Amir Mohammad Kazemifar
Journal:  Addict Health       Date:  2015 Winter-Spring
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.